Key result
Noradrenaline and phenylephrine used to elevate mean arterial pressure during cardiopulmonary bypass caused a similar, clinically non-significant 2.0% decrease in cerebral oxygen saturation.
Why the study?
Vasopressors counteract hypotension during cardiopulmonary bypass but alpha-agonists have been linked to cerebral desaturation, which can increase postoperative neurological dysfunction.
Does noradrenaline compared to phenylephrine affect cerebral oxygen saturation in patients undergoing elective cardiac surgery with cardiopulmonary bypass?
RCT (n=36)
Does noradrenaline compared to phenylephrine affect cerebral oxygen saturation in patients undergoing elective cardiac surgery with cardiopulmonary bypass?
Elevation in MAP mediated solely by vasopressors (noradrenaline or phenylephrine) induces statistically significant but clinically non-significant decreases in cerebral oxygen saturation during cardiac surgery under CPB.
Answers are grounded in this paper and cite their sources.
Clinically insignificant ScO2 drops with NA or PE during CPB warrant no practice change; leaves open neurological outcome effects in larger trials.
Cardiopulmonary bypass (CPB) in cardiac surgery is associated with a high risk of postoperative neurological complications. Perioperative use of vasopressors is common to counteract arterial hypotension in this setting. However, use of α‐agonist vasopressors has been associated with cerebral desaturations. Given that reductions in cerebral oxygen saturation () can increase postoperative neurological dysfunction, we aimed to investigate the impact of noradrenaline (NA) and phenylephrine (PE) on during the CPB period of a cardiac surgery in 36 patients scheduled for an elective cardiac surgery. Patients were randomized to the intra‐operative use of either NA or PE. During CPB, mean arterial pressure (MAP) was elevated pharmacologically to predefined thresholds of 60 and 80 mmHg, while CPB flow was kept constant. The values were recorded for 5 min per MAP threshold. The MAP increased adequately between thresholds of 60 and 80 mmHg (NA, 59 ± 3 vs. 81 ± 3 mmHg and PE, 61 ± 4 vs. 81 ± 3 mmHg; P ˂ 0.01). The decreased between pressure thresholds of 60 and 80 mmHg (NA, 70 ± 11 vs. 69 ± 11 mmHg and PE, 64 ± 11 vs. 63 ± 11 mmHg; P ˂ 0.01). Reduction in did not differ between vasopressors. The mean relative decrease in across groups was 2.0% (95% confidence interval: 0.6 to 2.1). Elevation in MAP mediated solely by vasopressors induces significant decreases in during cardiac surgery under CPB. However, their impact on remains clinically non‐significant according to current guidelines.
No takes yet. Share an insight, caveat, or question.
Marques et al. (2025) conducted an RCT in Elective cardiac surgery under cardiopulmonary bypass (n=36). Noradrenaline vs. Phenylephrine was evaluated on Cerebral oxygen saturation (mean relative decrease 2.0%, 95% CI 0.6 to 2.1, p=<0.01). Noradrenaline and phenylephrine used to elevate mean arterial pressure during cardiopulmonary bypass caused a similar, clinically non-significant 2.0% decrease in cerebral oxygen saturation.
Synapse has enriched 10 related papers. Consider them for comparative context: